Skip to content

U-Freight Group expands pharma capabilities

The U-Freight Group (UFL) is strengthening its presence in the pharmaceutical and medical logistics sector through a deepened strategic partnership and a major new contract win in China.

U-Freight Group expands pharma capabilities
Published: | 2 min read

The U-Freight Group (UFL) is strengthening its presence in the pharmaceutical and medical logistics sector through a deepened strategic partnership and a major new contract win in China.

The U-Freight Group

A year after signing a strategic cooperation agreement with Shanghai Hongyu Supply Chain Management Co (HYSC), U-Freight is now providing logistics fulfilment services for a new B2B e-commerce platform, recently launched by Fuji Trading, a subsidiary of HYSC. 

The fujihealthcare.cn platform is a B2B e-commerce initiative in China dedicated exclusively to the medical industry, offering a comprehensive suite of services including overseas procurement, international transportation, customs clearance, CIQ inspection, warehousing, order processing, payment collection, and final delivery.

U-Freight Group CEO Simon Wong said: “We are excited to build on our strategic partnership with HYSC through the innovative B2B e-commerce platform. As one of the first of its kind in China for the medical sector, this initiative presents a strong competitive advantage for our logistics operations and opens up new opportunities in high-value healthcare supply chains.”

In a further boost to its capabilities in the sector, U-Freight has also secured a major logistics contract from one of China’s leading medical organisations. The agreement covers the transport of temperature-sensitive pharmaceutical reefer containers from multiple European locations to designated ports across China.

The project, set to commence shortly, underscores U-Freight’s expertise in cold-chain logistics and its ability to deliver compliant, efficient, and reliable services within the demanding pharmaceutical segment. The scope includes end-to-end management of complex, temperature-controlled shipments, all conducted under strict adherence to international quality and safety standards.

Simon Wong added: “Winning this significant contract reaffirms our position as a trusted partner in global pharmaceutical logistics. It marks a key milestone for U-Freight and highlights our ability to manage sophisticated cross-continental cold-chain operations, while maintaining the highest standards of service and compliance.”

These developments reinforce U-Freight Group’s long-term commitment to expanding its footprint in the pharmaceutical and healthcare logistics industry, with strategic partnerships and high-value contracts paving the way for sustained growth and innovation.

About the author

PharmaManufacturing IQ Staff

An article written by the PharmaManufacturing IQ staff

All articles

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information

More in Supply Chain

See all

More from PharmaManufacturing IQ Staff

See all